Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -22.50 (-9.24%)
Bid:
222.00
Ask:
225.00
Spread: 3.00 (1.351%)
Market Cap: £128.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

18 Oct 2024 16:19

RNS Number : 8324I
MJ Gleeson PLC
18 October 2024
Β 

MJ GLEESON plc

Incorporated in England and Wales

Registration number: 09268016

LEI: 21380064K7N2W7FD6434

ISIN: GB00BRKD9Z53

Β 

Β 

18 October 2024

Β 

MJ Gleeson plc ("Gleeson" or the "Company")

Β 

Exercise of Options and Director/PDMR Dealing

Β 

The Company announces that on 17 October 2024, James Thomson and Stefan Allanson, Chairman and Chief Financial Officer respectively, exercised share options over 57,935 ordinary shares of 2 pence each in the capital of the Company ("Ordinary Shares"). The share options were granted under the Company's Annual and Deferred Bonus Plan in respect of bonuses earned for the year ended 30 June 2022. The share options will be satisfied with Ordinary Shares held within the Company's Employee Benefit Trust.

Β 

Subsequent to the exercise of the share options, Stefan Allanson has sold 10,532 ordinary shares at an average price of 620 pence per Ordinary Share in order to satisfy tax liabilities resulting from the exercise of the abovementioned options.

Β 

Following the completion of the exercise and the sale, the aggregate shareholdings of James Thomson and Stefan Allanson will be:

Β 

Name

Aggregate shareholding (Ordinary Shares)

Percentage of total voting rights

James Thomson

112,518

0.193%

Stefan Allanson

169,400

0.290%

Β 

Β 

Enquiries:

Β 

MJ Gleeson plc Tel: 44 1142 612 900

Leanne Johnson Company Secretary

Β 

LEI: 21380064K7N2W7FD6434

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

James Thomson

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chairman

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

MJ Gleeson plc

b)

Β 

LEI

Β 

Β 

21380064K7N2W7FD6434

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 2 pence each

Identification code

ISIN: GB00BRKD9Z53

b)

Β 

Nature of the transaction

Β 

Β 

Exercise of Options into Shares

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil (exercise of options)

35,594

d)

Β 

Aggregated information

- Aggregated volume

n/a

- Price

e)

Β 

Date of the transaction

Β 

Β 

17 October 2024

f)

Β 

Place of the transaction

Β 

Off market

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Stefan Allanson

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

MJ Gleeson plc

b)

Β 

LEI

Β 

Β 

21380064K7N2W7FD6434

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 2 pence each

Identification code

ISIN: GB00BRKD9Z53

b)

Β 

Nature of the transaction

Β 

Β 

1) Exercise of Options into Shares

2) Sale of Ordinary Shares

Β 

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

1) Nil (exercise of options)

2) 620 pence

1) 22,341

Β 

2) 10,532

d)

Β 

Aggregated information

- Aggregated volume

n/a

- Price

e)

Β 

Date of the transaction

Β 

Β 

17 October 2024

f)

Β 

Place of the transaction

Β 

1) Off market

2) London Stock Exchange (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHMPBATMTBBBRI
Date   Source Headline
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.